
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
ERT has announced a Virtual Visit solution that enables the continuation of clinical trials during and after current global stay-at-home mandates due to the COVID-19 outbreak. ERT’s Virtual Visit solution enables at-home consultations between patients and investigative site personnel via a dedicated, secure app or web interface.
For more information, click






